Gainers

  • Merus NV MRUS shares rose 52.3 percent to $22.85 in pre-market trading. Incyte Corporation INCY and Merus announced a global strategic research collaboration to discover and develop bispecific antibodies.
  • Calithera Biosciences Inc CALA rose 17.9 percent to $3.60 in pre-market trading. Bristol-Myers Squibb Co BMY and Calithera Biosciences disclosed a clinical collaboration to evaluate Opdivo in combination with CB-839 in clear cell renal cell carcinoma.
  • InvenSense Inc INVN shares rose 17 percent to $12.68 in pre-market trading after TDK Corp announced plans to acquire InvenSense for $13 per share in cash.
  • Lexicon Pharmaceuticals, Inc. LXRX shares rose 12.1 percent to $18.30 in pre-market trading after the company disclosed that its Phase 3 trial for sotagliflozin met its primary endpoint.
  • Danaos Corporation DAC shares rose 11.1 percent to $3.00 in pre-market trading after gaining 1.85 percent on Tuesday.
  • Inovio Pharmaceuticals Inc INO shares rose 11 percent to $7.69 in pre-market trading following Phase 1 Zika vaccine update.
  • Winnebago Industries, Inc. WGO rose 5.9 percent to $39.40 in pre-market trading after the company reported upbeat Q1 results.
  • Embraer SA (ADR) ERJ rose 5.2 percent to $18.67 in pre-market trading after declining 1.61 percent on Tuesday.
  • China Eastern Airlines Corp. Ltd. (ADR) CEA rose 4.1 percent to $22.3 in pre-market trading after slipping 0.42 percent on Tuesday.
  • Nike Inc NKE shares rose 2.3 percent to $53.00 in pre-market trading as the company posted stronger-than-expected results for its second quarter on Tuesday.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Losers

  • xG Technology Inc XGTI shares fell 54.7 percent to $1.64 in pre-market trading after the company reported the pricing of its $10 million offering.
  • Merrimack Pharmaceuticals Inc MACK fell 20.9 percent to $4.25 in pre-market trading after the company announced that it will stop a Phase 2 study of its treatment to fight breast cancer.
  • Finish Line Inc FINL shares fell 14.8 percent to $19.60 in pre-market trading after the company reported weaker-than-expected results for its fiscal third quarter and issued a downbeat forecast.
  • Sigma Designs Inc SIGM fell 12.9 percent to $5.05 in pre-market trading.
  • RedHill Biopharma Ltd - ADR RDHL fell 12.1 percent to $9.50 in pre-market trading. RedHill Biopharma reported a proposed concurrent public offering and registered direct offering.
  • Steelcase Inc. SCS shares fell 9.5 percent to $15.20 in pre-market trading after the company reported weak results for its third quarter.
  • Advanced Accelerator Application SA(ADR) AAAP shares fell 8.4 percent to $24.00 in pre-market trading after the company disclosed that it has received a Complete Response Letter from the FDA for Lutathera.
  • Delta Air Lines, Inc. DAL shares fell 3.5 percent to $49.00 in pre-market trading. Delta Air Lines and Aeroméxico agreed to establish a joint cooperation agreement.
  • Accenture Plc ACN fell 3.3 percent to $120.00 in pre-market trading after the company issued a weak outlook for the full year.
  • FedEx Corporation FDX fell 2.4 percent to $194.00 in pre-market trading after the company reported weaker-than-expected earnings for its second quarter on Tuesday.
Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!